New diabetes clinical trial: Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome
Published on: September 14, 2025 at 11:00PM
Conditions: Stroke; Coronary Arterial Disease (CAD); Myocardial Infarction (MI); Diabetes Mellitus; Peripheral Artery Disease (PAD); Chronic Kidney Disease(CKD); Albuminuria
Interventions: Dietary Supplement: Spirulina Arthrospira platensis (microalgae); Dietary Supplement: Gelidium corneum; Other: Placebo
Sponsors: Universidade do Porto; Centro Hospitalar De São João, E.P.E.
Recruiting
https://ift.tt/BQa6Ioj
Conditions: Stroke; Coronary Arterial Disease (CAD); Myocardial Infarction (MI); Diabetes Mellitus; Peripheral Artery Disease (PAD); Chronic Kidney Disease(CKD); Albuminuria
Interventions: Dietary Supplement: Spirulina Arthrospira platensis (microalgae); Dietary Supplement: Gelidium corneum; Other: Placebo
Sponsors: Universidade do Porto; Centro Hospitalar De São João, E.P.E.
Recruiting
https://ift.tt/BQa6Ioj
Comments
Post a Comment